Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for bioMérieux S.A. (BIM.PA), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
22.37
P/B ratioShare price divided by book value per share.
2.39
P/S ratioMarket value divided by annual revenue.
2.57
PEG ratioP/E divided by the earnings growth rate.
1.98
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
9.59
EV / RevenueEnterprise value against annual revenue.
2.53
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
4.47%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
56.13%
Operating marginRevenue left after operating costs.
15.23%
Net marginRevenue left after every cost, including tax and interest.
11.59%
Return on equityProfit as a percentage of shareholders’ equity.
11.22%
Return on assetsProfit as a percentage of total assets.
7.23%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.30
Quick ratioThe same, excluding inventory.
1.44
Debt to equityTotal borrowings against shareholders’ equity.
0.10
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$3.90
Book value per shareShareholders’ equity divided by shares outstanding.
$36.51
Shares outstandingShares currently issued.
117,692,084
Market capitalisationShare price times shares outstanding.
$10.27B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
1.14%
Payout ratioShare of profit paid out as dividends.